pindolol has been researched along with Injury, Myocardial Reperfusion in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nasa, Y | 1 |
| Hoque, AN | 1 |
| Ichihara, K | 1 |
| Abiko, Y | 1 |
| Jin, XZ | 1 |
| Liu, GD | 1 |
2 other studies available for pindolol and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Cardioprotective effect of pindolol in ischemic-reperfused isolated rat hearts.
Topics: Adenine Nucleotides; Animals; Fatty Acids, Nonesterified; Heart; Lactates; Lactic Acid; Male; Myocar | 1992 |
Prevention of postischemic reperfusion damage on isolated working rat hearts by bopindolol and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Heart Function Tests; In Vitro Techniques; Lipid Peroxidation; | 1989 |